MRD Tests and Applications — Rafael Fonseca, MD | MCRT Webcast August 29 (2/4)

How Should Patients Think About MRD? — Jeffrey Wolf, MD | MCRT Webcast August 29 (3/4)Подробнее

The role of MRD Testing in Myeloma | Rafael Fonseca, MD | ASH 2021Подробнее

What is your innovation vision for Mayo Clinic? Rafael Fonseca, M.D., Mayo ClinicПодробнее

MRD in multiple myeloma: determining responseПодробнее

Uses of MRD in patients with multiple myelomaПодробнее

MCRT Phoenix 2017: The Basics of Myeloma Genetics by Rafael Fonseca, MDПодробнее

Key Take Aways from IMS 2023 | Rafael Fonseca, MD | IMS 2023Подробнее

Minimal Residual Disease (MRD) Defined — Jeffrey Wolf, MD | MCRT Webcast August 29 (1/4)Подробнее

What is Multiple Myeloma? | Dr. Rafael Fonseca, M.D. | The Patient StoryПодробнее

Metabolomics | Rafael Fonseca, MD | IMS 2022Подробнее

MCRT Phoenix 2017: Determining the Right Therapy Strategy by Rafael Fonseca, MDПодробнее

What causes multiple myeloma? Rafael Fonseca, M.D., Mayo ClinicПодробнее

We Can and We WILL Cure Cancer! | Rafael Fonseca MD | TEDxEaglebrookSchoolПодробнее

Roundtable Audience Q&A — Full Faculty | MCRT Webcast August 29 (4/4)Подробнее

Pathological optimism: seeking a cure for multiple myeloma | Rafael Fonseca, M.D. | Mayo ClinicПодробнее

MCP 60 Seconds With Dr Rafael Fonseca on Cancer Drug PricingПодробнее

Dr. Fonseca on FISH Testing in Patients With MyelomaПодробнее

Rafael Fonseca, MD, discusses frontline multiple myeloma treatment patternsПодробнее